These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21286340)

  • 1. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis.
    Kuo YH; Lu SN; Hung CH; Kee KM; Chen CH; Hu TH; Lee CM; Changchien CS; Wang JH
    Hepatol Int; 2010 Oct; 4(4):700-6. PubMed ID: 21286340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography.
    Masuzaki R; Tateishi R; Yoshida H; Yoshida H; Sato S; Kato N; Kanai F; Sugioka Y; Ikeda H; Shiina S; Kawabe T; Omata M
    J Clin Gastroenterol; 2008 Aug; 42(7):839-43. PubMed ID: 18668703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis.
    Akima T; Tamano M; Hiraishi H
    Hepatol Res; 2011 Oct; 41(10):965-70. PubMed ID: 21883739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
    Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
    Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
    Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
    Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness.
    Dajti E; Marasco G; Ravaioli F; Colecchia L; Ferrarese A; Festi D; Colecchia A
    JHEP Rep; 2021 Jun; 3(3):100289. PubMed ID: 34095798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
    Jung KS; Kim SU; Ahn SH; Park YN; Kim DY; Park JY; Chon CY; Choi EH; Han KH
    Hepatology; 2011 Mar; 53(3):885-94. PubMed ID: 21319193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.
    Wang JH; Chuah SK; Lu SN; Hung CH; Kuo CM; Tai WC; Chiou SS
    Liver Int; 2014 Oct; 34(9):1340-8. PubMed ID: 24620731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.
    Wu HM; Sheng L; Wang Q; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Qiu DK; Hua J
    World J Gastroenterol; 2018 Feb; 24(6):737-743. PubMed ID: 29456412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
    Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M
    Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis.
    Jin YJ; Kim HY; Suh YJ; Lee CH; Yu JH; Kim MN; Han JW; Lee HA; An J; Chon YE; Jun DW; Choi M; Kim SU
    Clin Mol Hepatol; 2024 Sep; 30(Suppl):S159-S171. PubMed ID: 39038958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.
    Izumi T; Sho T; Morikawa K; Shigesawa T; Suzuki K; Nakamura A; Ohara M; Kawagishi N; Umemura M; Shimazaki T; Kimura M; Nakai M; Suda G; Natsuizaka M; Ogawa K; Kudo Y; Nishida M; Ono K; Baba M; Furuya K; Sakamoto N
    Hepatol Res; 2019 Oct; 49(10):1207-1217. PubMed ID: 31219667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
    Oh JH; Goh MJ; Park Y; Kim J; Kang W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Paik YH
    Dig Dis Sci; 2021 Aug; 66(8):2816-2825. PubMed ID: 32897445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.
    Chang PE; Hartono JL; Ngai YL; Dan YY; Lim KB; Chow WC
    Singapore Med J; 2019 Oct; 60(10):532-537. PubMed ID: 30556091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transient elastography accurately predicts the severity of disease in patients with chronic hepatitis B].
    Chen YP; Liang XE; Zhang Q; Dai L; Peng J; Hou JL
    Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):758-62. PubMed ID: 22176964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
    Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
    World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma.
    Lei JW; Ji XY; Hong JF; Li WB; Chen Y; Pan Y; Guo J
    BMC Gastroenterol; 2017 Dec; 17(1):171. PubMed ID: 29284411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of liver-stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct-acting antivirals: A systematic review and time-to-event meta-analysis.
    You MW; Kim KW; Shim JJ; Pyo J
    J Gastroenterol Hepatol; 2021 Mar; 36(3):601-608. PubMed ID: 32875681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.